PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
11-Jul-2025 ISS UK reaches £1 million milestone in apprenticeship levy gifting in 2025 ISS UK
11-Jul-2025 Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic Epitopea
11-Jul-2025 A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care KFSHRC
11-Jul-2025 Transgene Appoints Seasoned Industry Executive Emmanuelle Quilès to Board of Directors as Independent Director Transgene
10-Jul-2025 Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic Epitopea
10-Jul-2025 Bioengineered Protein Drugs Market Set to Soar with 8.22% CAGR, Says FutureWise Futurewise Research
09-Jul-2025 ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025 ViiV Healthcare
09-Jul-2025 Phesi CEO warns phase 3 trial failures loom as sponsors overlook real-world data and overcrowd investigator sites Phesi
08-Jul-2025 PrimeVigilance Enhances Efficiency and Patient Safety with Oracle Argus Platform PrimeVigilance
08-Jul-2025 Modus Therapeutics completes enrollment in Part 1 of the Phase IIa sevuparin study in chronic kidney disease with anemia Modus Therapeutics
08-Jul-2025 Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers Eleva
08-Jul-2025 Hyaluronic Acid Dermal Filler Market Poised to Surpass USD 10.8 Billion by 2033 Amid Rising Demand for Minimally Invasive Aesthetic Treatments Ameco Research
07-Jul-2025 First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy Pulsesight Therapeutics
07-Jul-2025 Tendonitis Treatment Market Crosses USD 223.7 Billion in 2024, Set to Surge Beyond USD 308 Billion by 2033 with Advancements in Regenerative Therapies Acumen Research and Consulting
04-Jul-2025 Asahi Kasei Pharma starts Phase III study of promising CIPN prevention therapy, ART-123 (Recomodulin™), to enhance treatment options worldwide Asahi Kasei Pharma
04-Jul-2025 Calcium Phosphate Bone Cement Market Set to Reach USD 1.33 Bn by 2033, Rising 5.6% CAGR on Surge in Minimally Invasive and Regenerative Orthopaedic Practices Ameco Research
04-Jul-2025 Everest CRO Shares Experience on Flex Databases' CTMS and eTMF Flex Databases
04-Jul-2025 CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research CD Bioparticles
04-Jul-2025 CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy CD Bioparticles
04-Jul-2025 Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development Creative Diagnostics